Related Experiment Videos
CD4(+)CD25high regulatory T cells in human pregnancy
Shigeru Saito1, Yasushi Sasaki, Masatoshi Sakai
1Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan. s30saito@ms.toyama-mpu.ac.jp
Journal of Reproductive Immunology
|April 7, 2005
Summary
CD4(+)CD25+ regulatory T (Treg) cells are crucial for immune tolerance in both humans and mice. However, their surface markers and specific functions differ between species, impacting transplantation and pregnancy outcomes.
Area of Science:
- Immunology
- Cell Biology
Background:
- CD4(+)CD25+ regulatory T (Treg) cells are vital for immune homeostasis.
- These cells prevent autoimmunity and rejection in transplantation and pregnancy.
Purpose of the Study:
- To review the differences in CD4(+)CD25+ Treg cell phenotypes between humans and mice.
- To explore the role of CD4(+)CD25+ Treg cells during pregnancy.
Main Methods:
- Comparative analysis of human and mouse CD4(+)CD25+ T cell populations.
- Review of literature on Treg cell function and surface markers.
Main Results:
- Murine CD4(+)CD25+ T cells are homogenous and regulatory.
- Human CD4(+)CD25high T cells are regulatory, while CD4(+)CD25low cells are not.
- Treg cells utilize cell-contact, cytokines (IL-10, TGF-β), and CTLA-4/IDO pathways for immunosuppression.
Conclusions:
- Significant phenotypic and functional differences exist between human and mouse CD4(+)CD25+ Treg cells.
- Understanding these differences is critical for advancing transplantation tolerance and managing pregnancy-related immune responses.